| Dr Natchez Joseph Morice Iii, MD | |
|
1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380-1326 | |
| (985) 702-2229 | |
| (985) 384-0329 |
| Full Name | Dr Natchez Joseph Morice Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 1216 N Victor Ii Blvd, Morgan City, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326022252 | NPI | - | NPPES |
| 07-02564 | Other | LA | UHC |
| 1165549 | Medicaid | LA | |
| 4F373 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14920R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thibodaux Regional Medical Center | Thibodaux, LA | Hospital |
| Entity Name | Natchez Morice, Md, Mba, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477850485 PECOS PAC ID: 3375726763 Enrollment ID: O20110322000930 |
News Archive
If men thought they were frittering away money wining and dining a girl to win her hand, they should think again.
Genzyme Corporation announced today that the European Commission has granted marketing authorization for Mozobil ® (plerixafor injection), providing a significant new option for patients with the blood cancers lymphoma and multiple myeloma who require an autologous stem cell transplant.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women, researchers report.
› Verified 3 days ago
| Entity Name | Urgent Care Of Morgan City Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407196686 PECOS PAC ID: 3779894092 Enrollment ID: O20150612001001 |
News Archive
If men thought they were frittering away money wining and dining a girl to win her hand, they should think again.
Genzyme Corporation announced today that the European Commission has granted marketing authorization for Mozobil ® (plerixafor injection), providing a significant new option for patients with the blood cancers lymphoma and multiple myeloma who require an autologous stem cell transplant.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women, researchers report.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natchez Joseph Morice Iii, MD 1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380-1326 Ph: (985) 702-2229 | Dr Natchez Joseph Morice Iii, MD 1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380-1326 Ph: (985) 702-2229 |
News Archive
If men thought they were frittering away money wining and dining a girl to win her hand, they should think again.
Genzyme Corporation announced today that the European Commission has granted marketing authorization for Mozobil ® (plerixafor injection), providing a significant new option for patients with the blood cancers lymphoma and multiple myeloma who require an autologous stem cell transplant.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women, researchers report.
› Verified 3 days ago
Dr. Julie E. S. Price, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1151 Marguerite St, Suite 700a, Morgan City, LA 70380 Phone: 985-221-4400 Fax: 985-221-4404 | |
Elizabeth Holt Zabel, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380 Phone: 985-702-2229 Fax: 985-384-0329 | |
Vicky J Griffin, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1151 Marguerite St, Morgan City, LA 70380 Phone: 985-221-4400 Fax: 985-221-4404 | |
Nsikan St Martin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 215 Everett St, Morgan City, LA 70380 Phone: 985-354-6081 |